Core Viewpoint - Huaxia Eye Hospital (301267) announced on September 26 that the new refractive surgery technique, Beijing Huaxia Minzhong All-Laser Femto 4.0, accounts for approximately 60% of refractive surgeries, excluding ICL implantation surgeries, indicating a significant market share and patient acceptance [1] Company Summary - The All-Laser Femto 4.0 technique offers higher precision compared to previous methods, with minimal price differences, leading to a higher acceptance rate among patients [1] - The company plans to introduce the new Zeiss minimally invasive All-Laser SMILE pro technology to further meet diverse patient needs in the future [1] Industry Summary - The adoption of advanced refractive surgery techniques like All-Laser Femto 4.0 reflects a growing trend in the ophthalmology sector towards more precise and patient-friendly surgical options [1]

Group 1: Business Structure and Revenue - The current revenue structure of Beijing Huaxia Minzhong Eye Hospital shows that refractive and optometry services account for approximately 40%, while cataract and other eye disease services account for about 60%. The hospital aims to increase the revenue share of refractive, optometry, and presbyopia services to 70%-80% in the future [2][3] - The proportion of new refractive surgical techniques, such as the all-laser femtosecond surgery (4.0), currently accounts for about 60% of refractive surgeries (excluding ICL implantation) [2][3] Group 2: Surgical Services and Market Trends - The volume of femtosecond cataract surgeries represents about 50% of the total cataract surgeries performed at the hospital. Despite being a fully self-funded service, patient acceptance is high due to the demand for superior visual experiences [3][4] - The medical payment system is evolving towards a combination of "medical insurance + commercial insurance + personal payment," which is a significant trend. The hospital focuses on differentiated services and technologies to meet patients' supplementary and enhanced medical needs, indicating strong market potential [3][4] Group 3: Competitive Advantages and Market Position - Beijing Huaxia Minzhong Eye Hospital has established a strong brand reputation in the Beijing market since its founding in 2008, supported by a dual-track expert model that includes both internal staff and renowned specialists [3][4] - The hospital has developed five major centers for various eye care services and possesses advanced diagnostic and treatment equipment, providing a competitive edge in expert resources, treatment capabilities, and academic research [3][4] Group 4: Future Goals and Development Plans - The hospital is one of six cities where Huaxia Eye Hospital Group plans to establish regional eye care centers. Future goals include optimizing revenue structure, introducing advanced technologies and equipment, and enhancing patient service levels to maintain a leading position in the high-end medical market in Beijing [4] - The new SMILE pro technique is being promoted across various hospitals under the group, with the Xiamen Eye Center achieving a milestone of 2,000 surgeries, making it the fastest single hospital to reach this number globally [4]